4 Medical Device M&A Deals I’d Like to See
On the heals of the Abbott – St. Jude deal, should Boston Scientific go in a completely different direction? What other medtech M&A deals should come to fruition? And how can medical device companies compete in the new era of bundled, value-based programs? These are just some of the topics covered in the...
Doctors Send $1.6M Per Year to Hospitals Despite the Value-Based Push
In this issue, learn how doctors are still an economic asset for most hospitals. Also, check out the piece written by Dr. Gary Guthard, the CEO of Intuitive Surgical. You also might find MD&DI’s article about value analysis teams to be worth a read. I’ve included a few other pieces that might...
Survey: Medical Reps Like the Money, Not Their Bosses
In this issue, learn why medical device reps like their jobs, just not their bosses. Also, check out S2N’s piece on advice for early-stage medtech CEOs. You also might find MD&DI’s article on the robotic space pretty interesting. I’ve included a few other pieces that might deserve your attention as...
Value-Based Payments: Don’t Ignore the Signs!
In this issue, learn why you can’t afford to ignore the value-based train that’s coming down the tracks. I’ve also highlighted a few different pieces regarding direct-to-patent changes within healthcare. And lastly, if you have questions regarding the 510(k) process, don’t forget to check out these tips....